Electrome Corporation

Precision Bioelectric Therapeutics for Pain, Infection, and Cancer

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Los Angeles, CA, USA
  • Currency USD
  • Founded March 2025
  • Employees 6
  • Incorporation Type C-corp
  • Website electrome.com

Company Summary

Electrome is building the first integrated hardware-software platform for decoding and programming the electrical layer of human biology. Our AI-driven platform uses digital twins, frequency modeling, and patent-pending applicator devices to modulate cellular signals and deliver precision bioelectric therapies for pain, inflammation, infection, and cancer targeting a $152B global market -- with our first FDA-cleared product line launching Q1-26.

Team

  • Co-founder & CMO

    Harvard-trained physician driving brain-focused R&D, past CMO of SoftPulse, leading innovator in brain MedTech. Experienced CMO leading critical brain-recovery MedTech.

  • Wanni Davis, PhD MBA
    COO

    Former director of Industry Partnerships at Harvard-affiliated Hospitals; biotech strategist with 15+ years in translational science, venture development, and commercialization; leading partnerships, BD, and alliance operations across the life sciences/biopharma ecosystem.

  • Erik Nilsen, PhD
    CTO

    DARPA-funded biophysicist with deep expertise in bioelectric signaling, medical devices, and applied physics. He has led multiple technology exits, authored 14+ patents, and built advanced bioelectric platforms across defense, biotech, and digital health. At Electrome, he drives R&D, AI-driven signal discovery, and the development of the programmable bioelectric therapeutics platform.

  • Sam Awad, MD
    Medical Director

    Nationally recognized surgeon-scientist with decades of leadership at the Houston VA and Baylor College of Medicine. He has led major clinical trials in post-operative care, pain, and wound healing, published extensively, and overseen large-scale VA research programs. At Electrome, he guides clinical strategy, evidence generation, and translation of bioelectric therapies into real-world care.

Previous Investors

  • Fredrick Crawford
    Unconfirmed
    Nigel Timothy
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free